JENA 10-K & 10-Q changes, risk factors and insider trading
JENA ACQUISITION Corp II (also JENA-RI, JENA-UN) · NYSE · Blank Checks · CIK 2060337 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
New heading “We have received a written notice from NYSE indicating that the Company is not currently in compliance with Section 802.01A of the NYSE Listed Company Manual which requires the Company to maintain a minimum of 300 public shareholders on a continuous basis. If we cannot regain compliance, our securities will be subject to delisting and the liquidity and the trading price of our securities could be adversely affected.”
Largest changes
“We have received a written notice from NYSE indicating that the Company is not currently in compliance with Section 802.01A of the NYSE Listed Company Manual which requires the Company to maintain a minimum of 300 public shareholders on a continuous basis. If we cannot regain compliance, our securities will be subject to delisting and the liquidity and the trading price of our securities could be adversely affected.”see in full comparison
“In addition, if our securities are delisted from NYSE, trading in our securities, and offers and sales of our securities by us, may be subject to state securities regulation and additional compliance costs.”see in full comparison
“On April 1, 2026, we received a written notice from NYSE indicating that the Company is not currently in compliance with Section 802.01A of the NYSE Listed Company Manual which requires the Company to maintain a minimum of 300 public shareholders on a continuous basis. On July 8, 2026, the Company was notified by NYSE that its business plan submission had been accepted. In accordance with NYSE rules, the Company will now have until October 1, 2027 to regain compliance with the continued listing standards. …”see in full comparison
“If NYSE were to suspend our securities from trading and delist our securities, our securities could potentially be quoted on an over-the-counter market. Even if our securities are then quoted on an over-the-counter market, our NYSE suspension and delisting could have significant material adverse consequences, including:”see in full comparison
Full comparison: every changed paragraph (5)
As a smaller reporting company
under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of
the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement,
(ii) 2025 Annual Report and (iii) Quarterly Reports on Form 10-Q for the quarterly periods ended June 30, 2025 as filed with the SEC on
August 13, 2025. As of the date of this Report, there have been no material changes with respect to those risk factors.factors, other than as
set forth below. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results
of operations or
financial condition. Additional risks not presently known to us or that we currently deem immaterial may also affect
our ability to consummate
an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors
from time to time in
our future filings with the SEC.
We have received a written notice from NYSE indicating that the Company is not currently in compliance with Section 802.01A of the NYSE Listed Company Manual which requires the Company to maintain a minimum of 300 public shareholders on a continuous basis. If we cannot regain compliance, our securities will be subject to delisting and the liquidity and the trading price of our securities could be adversely affected.
On April 1, 2026, we received a written notice from NYSE indicating that the Company is not currently in compliance with Section 802.01A of the NYSE Listed Company Manual which requires the Company to maintain a minimum of 300 public shareholders on a continuous basis. On July 8, 2026, the Company was notified by NYSE that its business plan submission had been accepted. In accordance with NYSE rules, the Company will now have until October 1, 2027 to regain compliance with the continued listing standards. The Company’s securities will continue to be listed on NYSE during such time, subject to the Company’s compliance with other continued listing standards. The Company will also be subject to quarterly monitoring by the NYSE for compliance with the plan. If the Company fails to comply with the plan or does not meet the continued listing standards at the end of the cure period, it will be subject to the prompt initiation of NYSE suspension and delisting procedures.
If NYSE were to suspend our securities from trading and delist our securities, our securities could potentially be quoted on an over-the-counter market. Even if our securities are then quoted on an over-the-counter market, our NYSE suspension and delisting could have significant material adverse consequences, including:
In addition, if our securities are delisted from NYSE, trading in our securities, and offers and sales of our securities by us, may be subject to state securities regulation and additional compliance costs.
Management's Discussion & Analysis (MD&A)
Largest changes
“Our mandatory liquidation in the event we do not complete a Business Combination within the Combination Period raises substantial doubt about our ability to continue as a going concern for a period of time within one year from the date of the accompanying unaudited condensed consolidated financial statements. Our Management plans to address this uncertainty by completing a Business Combination. …”see in full comparison
see in full comparisonWeIn connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” we do not currently believe we will need to raise additional funds to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
“On March 11, 2026, The Company advised Santander together with Kobre Capital LLC (“Kobre Capital”) that it intends to raise capital in connection with the Company’s proposed initial Business Combination with a Target. …”see in full comparison
Commencing on May 30, 2025 and until the completion of our Business Combination or liquidation, we reimburse the Sponsor $2,500 per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement. For the three and six months ended Junesee in full comparisonMarch30,31,2026,2026we incurred $7,500 and $15,000, respectively, in fees for these services, which amounts are included in accrued expenses in the condensed balance sheets of the financial statements included in this Report under Item 1. “Financial Statements”. For the three months ended June 30, 2025 and for the period from February 24, 2025 (inception) throughMarchJune31,30, 2025,wethereincurredhas$7,500beenand$2,742 accrued$0,under this agreement under accrued expenses infeestheforaccompanyingthese services,unauditedrespectively.condensed balance sheets.
“For the six months ended June 30, 2026, we had a net income of $2,977,402, which consists of dividend and interest earned on investments held in the Trust Account of $4,183,449, partially offset by formation, general, and administrative costs of $1,206,047. The increase in general and administrative costs is due to professional fees, due diligence, and other merger and acquisition related expenses.”see in full comparison
As ofsee in full comparisonMarchJune31,30, 2025, we hadhad no$1,185,540 cash and working capital deficit of$59,049.$1,223,796. For the period from February 24, 2025 (inception) throughMarchJune31,30,2026, net2025, cash used in operating activities was$0.$347,618. Net loss of$33,081$6,269,889 was affected by dividend and interest earned on investments held in Trust Account of $761,540 and payment offormation, general,general and administrative costs throughtheIPOpromissoryPromissorynoteNote– related party of$10,560.$63,310. Changes in operating assets and liabilities provided$22,521$6,620,501 of cash for operating activities.
Full comparison: every changed paragraph (19)
On April 1, 2026, we received a written notice (the “Notice”)
from the staff of NYSE Regulation of the NYSE indicating that
we are not currently in compliance with Section 802.01A of the NYSE Listed
Company Manual which requires us to maintain a minimum of 300 public
shareholders on a continuous basis. As permitted by the Listing Rule, we will,
we, within 45 days from the receipt of the Notice, submitsubmitted a
business plan to the NYSE that demonstratessought to demonstrate how we expectexpected to
return to compliance with the Listing Rule within 18 months of receipt of
the Notice. Upon receipt of the plan, the NYSE hashad 45 days to
review and determine if the plan reasonably demonstrates our ability to
regain compliance with the minimum listing standards. The Notice has
had no immediate impact on the listing or trading of the our securities.
We
have neither engaged in any operations nor generated any revenues to date. Our only activities since February 24, 2025 (inception) through
MarchJune 31,30, 2026 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering and (y) identifying
and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate
any operating revenues until after completion of our initial Business Combination. We have generated non-operating income in the form
of interest income on investments held in the Trust Account after the Initial Public Offering. We expect to incur increased expenses
as as
a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well
as as
for due diligence expenses.
For
the three months ended MarchJune 31,30, 2026, we had a net income of $1,096,230,$1,881,172, which consists of dividend and interest earned on investments
held held
in the Trust Account of $2,079,536,$2,103,913, partially offset by formation, general, and administrative costs of $983,306.$222,741. The increase in
general general
and administrative costs is due to professional fees, due diligence, and other merger and acquisition related expenses.
For
the periodthree frommonths Februaryended
June 24, 2025 (inception) through March 31,30, 2025, we had a net loss of $33,081,$6,236,808, which consists of formation, general,
and administrative costs.costs of $98,348, advisory fee
expense of $6,900,000, offset by dividend and interest earned on investments held in the Trust Account of $761,540.
For the six months ended June 30, 2026, we had a net income of $2,977,402, which consists of dividend and interest earned on investments held in the Trust Account of $4,183,449, partially offset by formation, general, and administrative costs of $1,206,047. The increase in general and administrative costs is due to professional fees, due diligence, and other merger and acquisition related expenses.
For the period from February 24, 2025 (inception) through June 30, 2025, we had a net loss of $6,269,889, which consists of formation, general, and administrative costs of $131,429, advisory fee expense of $6,900,000, offset by dividend and interest earned on investments held in the Trust Account of $761,540.
LiquidityLiquidity, Capital Resources, and Capital ResourcesGoing
Concern
As of MarchJune 31,30, 2026, we had
had $754,283$66,988 of cash and working capital of $303,921.$210,395. For the threesix months ended MarchJune 31,30, 2026, net cash used in operating activities
was $158,838. $846,133.
Net income of $1,096,230$2,977,402 was affected by dividend and interest earned on investments held in Trust Account of $2,079,536.
$4,183,449. Changes in
operating assets and liabilities provided $824,468$359,914 of cash for operating activities, of which majority of the changes are due
to increase
in accrued expenses and deferred legal fee pertaining to the amounts incurred in professional fees, due diligence, and other
merger and
acquisition related expenses.
As of MarchJune 31,30, 2025, we had
had no$1,185,540 cash and working capital deficit of $59,049.$1,223,796. For the period from February 24, 2025 (inception) through MarchJune 31,30, 2026, net2025, cash
used in operating activities was $0.$347,618. Net loss of $33,081$6,269,889 was affected by dividend and interest earned on investments held in
Trust Account of $761,540 and payment of formation, general,general and administrative costs through
the IPOpromissory Promissorynote Note– related party of $10,560.$63,310. Changes
in operating assets and liabilities provided $22,521$6,620,501 of cash for operating activities.
As of MarchJune 31,30, 2026, we had
had marketable securities held in the Trust Account of $237,529,528$239,633,441 (including approximately $2,079,536$2,103,913 and $4,183,449 of dividend and interest
earned earned
for the three and six months ended MarchJune 31,30, 20262026, respectively). We may withdraw interest from the Trust Account to pay taxes,
if any. We intend to use substantially
all of the funds held in the Trust Account, including any amounts representing interest earned
on the Trust Account (which interest shall
be net of taxes payable, if any, and exclude the Deferred Fee and Advisoryadvisory Feefee), to complete
our Business Combination. To the extent that
our share capital or debt is used, in whole or in part, as consideration to complete our
Business Combination, the remaining proceeds
held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions
and pursue our growth strategies.
As of MarchJune 31,30, 2026, we had
had cash held outside of the Trust Account of approximately $754,283.$66,988. We use the funds held outside the Trust Account primarily to identify
and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants,
or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements
of prospective target businesses, and structure, negotiate and complete a Business Combination.
In connection with our assessment
of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements – Going Concern,”
as of MarchJune 31,30, 2026, our Management has determined that we have access to funds from our Sponsor, and our Sponsor has the financial wherewithal
to fund us, that are sufficient to fund our working capital needs until the consummation of a Business Combination or for a minimum of
one year from the date of issuance of the accompanying unaudited condensed financial statements. We cannot provide any assurance that
our plans to consummate an initial Business Combination will be successful.
Our mandatory liquidation in the event we do not complete a Business Combination within the Combination Period raises substantial doubt about our ability to continue as a going concern for a period of time within one year from the date of the accompanying unaudited condensed consolidated financial statements. Our Management plans to address this uncertainty by completing a Business Combination. If a Business Combination is not consummated by the end of the Combination Period, currently May 30, 2027, there will be a mandatory liquidation and subsequent dissolution of us, which raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after the Combination Period. We intend to complete the initial Business Combination before the end of the Combination Period. However, there can be no assurance that we will be able to consummate any Business Combination by the end of Combination Period.
In order to fund working
capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers
and and
directors or their affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required. If we complete a
Business Business
Combination, we intend to repay such Working Capital Loans. In the event that a Business Combination does not close, we may
use a portion
of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust
Account would
be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business
Combination Combination
entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. Other than as set forth
above, the
terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such
Working Capital
Loans. As of MarchJune 31,30, 2026 and December 31, 2025, we did not have any borrowings under any Working Capital Loans.
WeIn connection with our assessment
of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,”
we do not currently believe we will
need to raise additional funds to meet the expenditures required for operating our business. However,
if our estimate of the costs of
identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination
are less than the actual amount
necessary to do so, we may have insufficient funds available to operate our business prior to our Business
Combination. Moreover, we may
need to obtain additional financing either to complete our Business Combination or because we become obligated
to redeem a significant
number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional
securities or incur debt
in connection with such Business Combination.
Commencing
on May 30, 2025
and until the completion of our Business Combination or liquidation, we reimburse the Sponsor $2,500 per month for office
space, utilities,
and secretarial and administrative support pursuant to the Administrative Services Agreement. For the three and six months ended June
March30, 31,2026, 2026we incurred $7,500 and $15,000, respectively, in fees for these services, which amounts are included in accrued expenses in
the condensed balance sheets of the financial statements included in this Report under Item 1. “Financial Statements”. For
the three months ended June 30, 2025 and for the period from February 24, 2025 (inception) through MarchJune 31,30, 2025, wethere incurredhas $7,500been and$2,742
accrued $0,under this agreement under accrued expenses in feesthe foraccompanying these
services,unaudited respectively.condensed balance sheets.
PIPE Agent Fee
On March 11, 2026, The Company
advised Santander together with Kobre Capital LLC (“Kobre Capital”) that it intends to raise capital in connection with the
Company’s proposed initial Business Combination with a Target. The Company engaged Santander to act as Agent and Kobre Capital to
act as its co-exclusive placement Agent in connection with the proposed Private Placement of equity or other securities of the Company
(including equity-linked or debt) (the “PIPE Securities”), the proceeds of which will be used to fund the business of the
combined consolidated company resulting from the Transaction (the “Combined Entity”). As compensation for the Agent’s
services as placement agents, the Company agrees to pay the Santander and Kobre Capital a placement fee equal to 2.150% and 0.850%, respectively,
of the gross proceeds received from PIPE Purchasers in the Private Placement in connection with the Transaction (excluding any Excluded
Investors). Any placement fee shall be deemed earned upon the closing with respect to each such PIPE purchaser of the purchase of PIPE
Securities by such purchaser of PIPE Securities pursuant to the terms of the PIPE subscription agreements between the Company and any
purchaser of PIPE Securities other than the Excluded Investors and such placement fees shall be paid in full at the closing of the Private
Placement or, in the event of multiple fundings or drawings are contemplated in the PIPE subscription agreements, each closing of the
Private Placement with respect to the amount funded or drawn at such closing with respect to such PIPE purchaser.
The
preparation of the unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial
Statements”
in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets
and liabilities,
income and expenses, and the disclosure of contingent assets and liabilities, in our unaudited condensed financial statements.
These accounting
estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation.
Management bases
its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances,
the results
of which form the basis for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience
differs differs
from the assumptions used, our unaudited condensed financial statements and notes thereto included in this Report under Item
1. “Financial
Statements” could be materially affected. We believe that the following accounting policies involve a higher
degree of judgment
and complexity. As of MarchJune 31,30, 2026, we did not have any critical accounting estimates to be disclosed.
JENA insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding JENA (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 725,000 | $7.5M | 0.01% | No change |
| D. E. Shaw & Co. | 2026-06-30 | 475,000 | $5.1M | — | Sold out |
| D. E. Shaw & Co. | 2026-06-30 | 475,100 | $4.9M | 0.0% | New position |
| Millennium Management (Israel Englander) | 2026-06-30 | 441,500 | $4.6M | 0.0% | No change |
| Millennium Management (Israel Englander) | 2026-06-30 | 200,000 | $2.2M | 0.0% | No change |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 43,853 | $472.7K | 0.0% | Added 7% |
| Millennium Management (Israel Englander) | 2026-06-30 | 626,206 | $106.5K | 0.0% | No change |
| D. E. Shaw & Co. | 2026-06-30 | 475,000 | $80.8K | 0.0% | New position |